Medicenna Therapeutics Corp (MDNA.TO) has had an eventful week, marked by a recent public offering.
This week, Medicenna's stock price increased by 10.84%, despite a slight decline of 2.13% on the last trading day. The company recently closed a public offering, raising about CDN$4.44 million, which could influence its financial position moving forward.
Investor takeaway: Keep an eye on how the capital raised from the public offering might affect Medicenna's ongoing clinical programs and overall market performance.
Advertisement
Medicenna Therapeutics Corp
MDNA.TO
MDNA.TO
Medicenna Therapeutics Corp
WealthAwesomeMarket cap
$43.84M
52W high
$1.97
52W low
$0.34
1W change
+10.84%
Beta
1.89
Analyst Price Targets
Based on analyst covering MDNA
Wall Street analysts forecast MDNA stock price to rise 595.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.20
+595.7% Upside
Current Price
C$0.46
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDNA's historical volatility
30-Day Vol
62.3%
Annualized
90-Day Vol
71.0%
Annualized
Trend (90d)
+38.2%
Annualized drift
90d Mean
C$0.53
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.48 | C$0.39 – C$0.60 |
| 60 trading days | C$0.50 | C$0.37 – C$0.68 |
| 90 trading days | C$0.53 | C$0.36 – C$0.77 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Medicenna's stock has risen 10.84% this week, closing at C$0.47.
The stock's performance this week contrasts sharply with its year-to-date decline of 54.00%, reflecting volatility and shifts in investor sentiment.
Bull case
The successful closing of the public offering gives Medicenna crucial funds to advance its clinical programs. This could boost investor confidence and generate more market interest.
Bear case
Despite the recent rise in stock price, Medicenna's overall year-to-date performance is still negative. Its reliance on public offerings might raise concerns about long-term sustainability.
Price Action Overview
Advertisement
Medicenna Therapeutics Corp (MDNA.TO) saw significant price action this week, with shares closing at C$0.47, reflecting a 10.84% increase. However, the stock fell by 2.13% on the last trading day, indicating some volatility amid the gains.
Recent Company News
This week, Medicenna announced the closing of a public offering that raised approximately CDN$4.44 million. The offering was priced at CDN$0.50 per unit and included units consisting of one common share and one-half warrant. This capital is intended to support the company’s lead programs, potentially enhancing its operational capabilities as it continues to develop its clinical pipeline.
Technical Picture
From a technical standpoint, Medicenna’s last close of C$0.47 is above its 50-day moving average of C$0.39, suggesting a positive short-term trend. However, it remains significantly below the 200-day moving average of C$0.73, indicating longer-term challenges. The stock's 52-week range has been between C$0.34 and C$1.97, with its current price representing 9% of this range. The beta of 1.89 suggests higher volatility compared to the broader market. Trading volume was notably low at 9,153 shares, which is only 0.51 times the 20-day average volume of 51,582 shares.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
